Malaria is a life-threatening parasitic disease transmitted by Anopheles mosquitoes, causing cyclical fever, chills, and anemia. Plasmodium falciparum causes the most severe form; artemisinin-based combination therapy is the first-line treatment.
Giemsa-stained peripheral blood smears examined under microscopy to identify malaria parasites, determine species, and quantify parasitaemia.
Lateral flow test detecting P. falciparum HRP2 antigen or pan-Plasmodium pLDH — the WHO-recommended point-of-care malaria test for endemic settings.
PCR amplification of parasite DNA from peripheral blood — high sensitivity for blood-borne parasites with species-level and drug resistance identification.
Artemether is an antimalarial agent used to prevent or treat malaria caused by Plasmodium species.
Artesunate is a fast-acting artemisinin-based antimalarial used for severe and complicated malaria, recommended by WHO as the first-line treatment for severe P. falciparum malaria.
Chloroquine is an antimalarial agent used to prevent or treat malaria caused by Plasmodium species.
Quinine is an antimalarial agent used to prevent or treat malaria caused by Plasmodium species.
Mefloquine is an antimalarial agent used to prevent or treat malaria caused by Plasmodium species.
Primaquine is an antimalarial agent used to prevent or treat malaria caused by Plasmodium species.
Describe your symptoms and get a structured AI clinical assessment — possible causes, urgency level, and recommended next steps.
Start Free AI Analysis →Content on this page is informed by evidence-based clinical sources including: